ArticleIBRO neuroscience reports2026
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fibromyalgia (FM) is a complex, chronic disorder characterized by widespread pain, fatigue, cognitive impairment, and sleep disturbances, and it is considered the second most prevalent rheumatic condition. Current pharmacological therapies are often associated with undesirable side effects, underscoring the need for safer, natural therapeutic alternatives. Methods: This study investigated the therapeutic effects of Results: Mice with reserpine-induced FM exhibited reduced body weight, decreased paw withdrawal threshold and thermal latency, diminished locomotor activity and grooming behavior, impaired spontaneous alternation, and prolonged immobility time. Histopathological examination revealed marked structural disruption of hippocampal tissue, accompanied by reduced serotonin levels and elevated concentrations of IL-1β, TNF-α, and NO compared with control animals. Treatment with Conclusions: These findings indicate that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.